Form 8-K - Current report:
SEC Accession No. 0001214659-21-000503
Filing Date
2021-01-14
Accepted
2021-01-14 16:30:19
Documents
6
Period of Report
2021-01-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 s1102108k.htm 8-K 23352
2 EXHIBIT 10.1 ex10_1.htm EX-10.1 161358
3 EXHIBIT 99.1 ex99_1.htm EX-99.1 14581
4 GRAPHIC eversana_logo.jpg GRAPHIC 16293
5 GRAPHIC eversana_logosm.jpg GRAPHIC 11063
6 GRAPHIC hgen_logo.jpg GRAPHIC 6614
  Complete submission text file 0001214659-21-000503.txt   247731
Mailing Address 533 AIRPORT BLVD. SUITE 400 BURLINGAME CA 94010
Business Address 533 AIRPORT BLVD. SUITE 400 BURLINGAME CA 94010 650.243.3100
HUMANIGEN, INC (Filer) CIK: 0001293310 (see all company filings)

EIN.: 770557236 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35798 | Film No.: 21529087
SIC: 2834 Pharmaceutical Preparations